Management of Overt Hepatic Encephalopathy

被引:22
|
作者
Khungar, Vandana [1 ,2 ]
Poordad, Fred [1 ,3 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA
关键词
Hepatic encephalopathy; Liver disease; Cirrhosis; Overt hepatic encephalopathy; INTRAHEPATIC PORTOSYSTEMIC SHUNT; ORNITHINE-L-ASPARTATE; PORTAL-SYSTEMIC ENCEPHALOPATHY; RANDOMIZED CONTROLLED-TRIAL; ORAL ZINC SUPPLEMENTATION; DOUBLE-BLIND; RIFAXIMIN TREATMENT; LIVER-CIRRHOSIS; CLINICAL-TRIAL; AMMONIA LEVELS;
D O I
10.1016/j.cld.2011.12.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic encephalopathy (HE) is a potentially reversible state of impaired cognitive function or altered consciousness in patients with liver disease or portosystemic shunting. Overt HE is a particularly pressing problem. Given the many targets of treatment and lack of a clear singular cause of overt HE, there is no consensus on a single best treatment. Over the past several years, high-quality studies have been conducted on the various pharmacologic therapies for HE and, as more data emerge, hopefully HE will become a much more easily treated complication of decompensated liver disease.
引用
收藏
页码:73 / +
页数:18
相关论文
共 50 条
  • [31] Probiotics in management of hepatic encephalopathy
    Sharma, Barjesh Chander
    Singh, Jatinderpal
    METABOLIC BRAIN DISEASE, 2016, 31 (06) : 1295 - 1301
  • [32] Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy
    Greinert, Robin
    Zipprich, Alexander
    Simon-Talero, Macarena
    Stangl, Franz
    Ludwig, Christiane
    Wienke, Andreas
    Praktiknjo, Michael
    Hoehne, Kevin
    Trebicka, Jonel
    Genesca, Joan
    Ripoll, Cristina
    LIVER INTERNATIONAL, 2020, 40 (12) : 3093 - 3102
  • [33] A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
    Pantham, Ganesh
    Post, Anthony
    Venkat, Deepak
    Einstadter, Douglas
    Mullen, Kevin D.
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (08) : 2166 - 2173
  • [34] Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
    Faccioli, Jessica
    Nardelli, Silvia
    Gioia, Stefania
    Riggio, Oliviero
    Ridola, Lorenzo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [35] Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy
    C. S. Landis
    M. Ghabril
    V. Rustgi
    A. M. Di Bisceglie
    B. Maliakkal
    D. C. Rockey
    J. M. Vierling
    J. Bajaj
    R. Rowell
    M. Santoro
    A. Enriquez
    M. Jurek
    M. Mokhtarani
    D. F. Coakley
    B. F. Scharschmidt
    Digestive Diseases and Sciences, 2016, 61 : 1728 - 1734
  • [36] Overt Hepatic Encephalopathy: More Than Meets the Eye
    Erminelli, Davide
    Mangini, Chiara
    Zarantonello, Lisa
    Angeli, Paolo
    Montagnese, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (09) : 1930 - 1934
  • [37] Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy
    Landis, C. S.
    Ghabril, M.
    Rustgi, V.
    Di Bisceglie, A. M.
    Maliakkal, B.
    Rockey, D. C.
    Vierling, J. M.
    Bajaj, J.
    Rowell, R.
    Santoro, M.
    Enriquez, A.
    Jurek, M.
    Mokhtarani, M.
    Coakley, D. F.
    Scharschmidt, B. F.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (06) : 1728 - 1734
  • [38] Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach
    Yanny, Beshoy
    Winters, Adam
    Boutros, Sandra
    Saab, Sammy
    CLINICS IN LIVER DISEASE, 2019, 23 (04) : 607 - +
  • [39] A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
    Ganesh Pantham
    Anthony Post
    Deepak Venkat
    Douglas Einstadter
    Kevin D. Mullen
    Digestive Diseases and Sciences, 2017, 62 : 2166 - 2173
  • [40] Disaccharides in the treatment of hepatic encephalopathy
    Sharma, Praveen
    Sharma, Barjesh Chander
    METABOLIC BRAIN DISEASE, 2013, 28 (02) : 313 - 320